Based on the in silico studies, such as molecular docking, ADMET characteristics predication, and MD, some phenalenones were found to possess remarkable capacity as GLUT1 inhibitors; therefore, they could be potential leads for cancer treatment. The gene discussed is SLC2A1; the disease is cancer.